HANDIPLASMID Trademark

Trademark Overview


On Thursday, June 15, 2023, a trademark application was filed for HANDIPLASMID with the United States Patent and Trademark Office. The USPTO has given the HANDIPLASMID trademark a serial number of 98044790. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2024. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The HANDIPLASMID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Developing new products for others; development of biological medicines; scientific research and development; antibody drug, mRNA vaccine medicine research; research and development of new products; consulting services in the field of technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies
handiplasmid

General Information


Serial Number98044790
Word MarkHANDIPLASMID
Filing DateThursday, June 15, 2023
Status700 - REGISTERED
Status DateTuesday, November 5, 2024
Registration Number7560866
Registration DateTuesday, November 5, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized word HanDIPlasmid with the "H" comprised of two hands and a double helix, the "P" is comprised of a folded ribbon and the dot of the "i" is the design of a gear.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDeveloping new products for others; development of biological medicines; scientific research and development; antibody drug, mRNA vaccine medicine research; research and development of new products; consulting services in the field of technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2023
Primary Code042
First Use Anywhere DateMonday, April 29, 2024
First Use In Commerce DateMonday, April 29, 2024

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 19, 2023NEW APPLICATION ENTERED
Wednesday, July 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 20, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 3, 2023ASSIGNED TO EXAMINER
Tuesday, October 17, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 17, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 22, 2024USE AMENDMENT FILED
Wednesday, May 22, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, June 29, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT